Abstract
Cabozantinib inhibits a variety of cellular receptors including VEGFR1-3, MET, AXL, RET, FLT3 and KIT. These signaling pathways have been shown to be ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
